Q1FY21e EPS expected to rise by 232% y-o-y; EPS for FY21-22e up 11% due to tax rate; top pick among…
Pricing outlook for core business is weak; FY21-22e Ebitda down 6-17%; TP raised to Rs 635 due to rise in…
Company to handle crisis well and is on track to gain market share in FY21; ‘Buy’ retained with TP of…
Company likely to navigate crisis better than peers; ‘Buy’ maintained with TP of Rs 585.
Wipro’s challenge has been a sub-optimal mix of clients where hunting and new logo efforts could have been better.
Asset growth, likely to be soft for two quarters, will revive faster than peers; company to consolidate its positioning; ‘Buy’…
But for Covid-19, volume scenario for FY21 was bright; dividend outlook and execution of 1.2-mtpa project behind ‘Buy’ rating
FY21E EPS cut by 10-27% and target price by 16-34%; companies downgraded to ‘Hold’ rating from Buy
Recovery is expected in Q2; upgraded to ‘Add’ given recent correction and other positives; TP cut to Rs 1,310.
Margins expected to fall in CY20e; downgraded to ‘Add’ with reduced TP of Rs 330
There’s absence of catalysts to narrow holdco and conglomerate discount that has risen of late; ‘Hold’ retained with TP of…
The prolonged lockdown in Q1 and expected decline in volumes of discretionary-based products (plywood and laminates) in near term is…
CY20e Ebitda cut by 7% to factor in Covid-19; valuation is attractive; ‘Buy’ retained.
Prospects for US business remain strong; TP raised to Rs 824 from Rs 578; ‘Buy’ retained; re-rating likely after VAI…
Near-term concerns over Covid-19 remain; ‘Buy’ retained with unchanged TP of Rs 447
FY20/21e EPS down 7/24% to factor in challenges; TP cut to Rs 72; ‘Buy’ retained
15.9/34.7% cut in FY20/21 EPS due to COVID-19; TP down to Rs 754; upgraded to ‘Buy’ given sharp correction
We expect start-up funding to be lower once the situation normalises, resulting in lower competition for the branded QSRs.
